Add like
Add dislike
Add to saved papers

A concise minimum eight year follow-up of proximally porous-coated tapered titanium femoral stem in primary total hip arthroplasty.

PURPOSE: Our goal was to assess clinical and radiographic outcomes using a second-generation circumferentially proximally porous-coated titanium alloy stem at a minimum of eight years of follow-up.

METHODS: Ninety-one hips (80 patients) with Fibre Metal Taper (FMT, Zimmer Inc, Warsaw, IN, USA) femoral stems implanted between May 1998 and April 2002 were followed prospectively and re-evaluated at a minimum of eight years postoperatively. The median patient age was 56 (range 34-78) years, with 40 women and 40 men. Radiographic data and clinical follow-up using Harris Hip Score (HHS) and EuroQol (EQ)-5D outcome measures were evaluated.

RESULTS: Mean follow-up was 9.61 (range 8-12.3) years. At the time of the most recent follow-up, the mean HHS was 85.8 (range 46-100) points, mean EQ-5D Weighted Health State Index was 0.76 (range 0.05-1.00), and mean EQ-5D Visual Analogue Score was 80 (range 24-100). All stems were biologically stable, with all hips having osseous ingrowth. One stem was revised due to early periprosthetic fracture with stem subsidence. No hip had diaphyseal osteolysis.

CONCLUSIONS: To our knowledge, the data presented here represent the longest clinical follow-up of this second-generation cementless, proximally porous-coated femoral stem. The stems were found to perform well clinically and radiographically beyond the first five years previously reported in the literature. Patients had high levels of satisfaction and function, and osseous fixation occurred reliably without evidence of distal osteolysis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app